Clinical Trials Directory

Trials / Unknown

UnknownNCT06268561

Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months

Status
Unknown
Phase
Study type
Observational
Enrollment
8 (estimated)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

OZURDEX endophthalmitis is a rare and potentially very serious pathology. Different treatments can be carried out early and change the functional prognosis of the patient.

Conditions

Interventions

TypeNameDescription
OTHERVisual acuity analysisCollection of information on visual acuity from the medical file concerning the surgery
OTHERIntraocular pressure analysisCollection of information on intraocular pressure from the medical file concerning the surgery
OTHERAnalysis of optical coherence tomography (OCT) imagesCollection and analysis of optical coherence tomography (OCT) images of the medical file concerning the surgery
OTHERAnalysis of retinogramsCollection and analysis of retinography images of the medical file concerning the surgery

Timeline

Start date
2023-06-05
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2024-02-20
Last updated
2024-02-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06268561. Inclusion in this directory is not an endorsement.